These results suggest that the effects of FOXO1 associated with TGF-β1 more potently affect N-cadherin expression compared with E-cadherin expression and indicate that FOXO1 expression in HCC cells inhibits TGF-β signaling. This evidence concerns the gene CDH2 and hepatocellular carcinoma.